Sandhya Girish

5.6k citations
106 papers · 4.2k · 1 hit paper · h-index 30

Impact in

  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • CAR-T cell therapy research
    • Cancer Treatment and Pharmacology
    • Peptidase Inhibition and Analysis
    • Cancer Immunotherapy and Biomarkers
    • Monoclonal and Polyclonal Antibodies Research

Papers in

    • HER2/EGFR in Cancer Research 71
    • Cancer Treatment and Pharmacology 11
    • Cancer Immunotherapy and Biomarkers 8
    • Peptidase Inhibition and Analysis 6
    • Monoclonal and Polyclonal Antibodies Research 38

Sandhya Girish

104 papers receiving 4.0k citations

Sandhya Girish's Hit Papers

Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy 2010 · 576 citations
5760+5+10Years since publication100200300400500

Peers

Sandhya Girish
Comparison fields: 5 of 98
  • Oncology 3.0k
  • Radiology, Nuclear Medicine and Imaging 1.9k
  • Immunology 521
  • Genetics 247
  • Cancer Research 178
Replace Michael W. Lu with:
Michael W. Lu United States
Stanford J. Stewart United States
Emma Clark United Kingdom
Laslo Roman Russia
José Luiz Pedrini Brazil
Sharon A. Baughman United States
Ajai Chari United States
Laleh Amiri‐Kordestani United States
Kirsten B. Goldberg United States
Antoinette R. Tan United States
Sandhya Girish relative to Michael W. Lu United States Michael W. Lu's profile →
Citations per field
00.5×2.6×
Michael W. Lu · 1×
Citations per year

Countries citing papers authored by Sandhya Girish

Since Specialization
Citations

This map shows the geographic impact of Sandhya Girish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandhya Girish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandhya Girish more than expected).

Fields of papers citing papers by Sandhya Girish

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandhya Girish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandhya Girish. The network helps show where Sandhya Girish may publish in the future.

Co-authors

The 25 scholars most cited alongside Sandhya Girish, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandhya Girish Line = papers co-authored together Sandhya Girish links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy
Hit paper breakdown →
2010576
2 2010440
3 2011346
4 2012279
5 2012199
6 2020193
7 2014158
8 2013140
9 2016117
10 201293
11 201275
12 200872
13 201267
14 201465
15 201963
16 201157
17 201657
18 201854
19 201947
20 201246

About Sandhya Girish

Sandhya Girish is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Genetics and Hematology, having authored 106 papers that have together received 4.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (71 papers), Monoclonal and Polyclonal Antibodies Research (38 papers), Advanced Breast Cancer Therapies (12 papers), Cancer Treatment and Pharmacology (11 papers), Cancer Immunotherapy and Biomarkers (8 papers), Chronic Lymphocytic Leukemia Research (8 papers), Breast Cancer Treatment Studies (6 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Oncology (3.0k citations), Radiology, Nuclear Medicine and Imaging (1.9k citations), Immunology (521 citations), Genetics (247 citations) and Cancer Research (178 citations). Sandhya Girish has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Ian E. Krop, Mark X. Sliwkowski, Howard A. Burris, Patricia LoRusso, Ellie Guardino, Joo‐Hee Yi, Shanu Modi, Jay Tibbitts, Hope S. Rugo and Scott N. Holden. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer Research, Clinical and Translational Science and Clinical Pharmacokinetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact